Christopher Snell

Christopher Ronald Snell, PhD, is the Scientific Director of Workwell Foundation, Ripon, California. He directs the Pacific Fatigue Lab at the Department of Health, Exercise, and Sport Sciences, at the University of the Pacific, Stockton, California, USA.

Chronic Fatigue Syndrome Advisory Committee
Dr. Snell was Chair of the Health and Human Services's Chronic Fatigue Syndrome Advisory Committee committee from 04/01/07-04/01/11.

Open letter to The Lancet
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Snell, along with 41 colleagues in the ME/CFS field, signed the second letter.
 * 10 February 2016, An open letter to The Lancet, again - Virology blog

Notable studies

 * 2013, Discriminative Validity of Metabolic and Workload Measurements for Identifying People With Chronic Fatigue Syndrome FULL TEXT
 * 2012, Minimum data elements for research reports on CFS FULL TEXT
 * 2011, Reliability and validity of Short Form 36 Version 2 to measure health perceptions in a sub-group of individuals with fatigue ABSTRACT
 * 2011, Diagnostic accuracy of symptoms characterising chronic fatigue syndrome ABSTRACT
 * 2010, Post-exertional malaise in women with chronic fatigue syndrome ABSTRACT
 * 2010, Conceptual model for physical therapist management of chronic fatigue syndrome/myalgic encephalomyelitis ABSTRACTFULL TEXT
 * 2007, Legal and Scientific Considerations of the Exercise Stress Test ABSTRACT
 * 2007, Diminished Cardiopulmonary Capacity During Post-Exertional Malaise ABSTRACT
 * 2005, Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS) FULL TEXT
 * 2004, Immunologic Aspects of Chronic Fatigue Syndrome: Report on a Research Symposium Convened by The CFIDS Association of America and Co-Sponsored by the US Centers for Disease Control and Prevention and the National Institutes of Health ABSTRACT
 * 2003, Subclassifying chronic fatigue syndrome through exercise testing ABSTRACT
 * 2002, Physical performance and prediction of 2-5A synthetase/RNase L antiviral pathway activity in patients with chronic fatigue syndrome ABSTRACT
 * 2001, Assessment of Functional Impairment by Cardiopulmonary Exercise Testing in Patients with Chronic Fatigue Syndrome ABSTRACT
 * 2001, Chronic Fatigue Syndrome, Ampligen, and Quality of Life: A Phenomenological Perspective ABSTRACT

Talks and interviews

 * 2016, 12th International IACFS/ME Biennial Clinical and Research Conference, Emerging Science and Clinical Care, How Cardiopulmonary Exercise Testing Informs Pathology and Treatment(Workshop given with Mark VanNess, Ph.D. and Betsy Keller, Ph.D.)
 * 2011, National Institutes of Health (NIH) State of the Knowledge Workshop regarding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Research presenter
 * Cardiopulmulmonary Exercise Testing to Assess fatigue in ME/CFS (presentation starts at the 8:02:00 time marker)

Learn more

 * 2012, Clinical exercise testing in CFS/ME research and treatment